Porcine Factor VIII
In the Monday afternoon session on alternative therapies in the management of inhibitors, Rebecca Kruse-Jarres discusses the latest developments in the use of porcine factor VIII.
Report on the Annual Global Survey 2015
Compiled annually, the Annual Global Survey (AGS) provides demographic and other data on people with hemophilia, von Willebrand disease, other rare factor deficiencies, and inherited platelet disorders throughout the world.
WFH Webinar: Treatment Options for Hemophilia in the Developing World
On December 16, 2016, the WFH in collaboration with the ISTH, recorded a live interactive webinar on the challenges and opportunities of treatment options for hemophilia in the developing world, now available for viewing here. Introduced by Marijke van den Berg, Rolf Ljung opened with a summary of the lessons learned from decades of experience […]
ePosters of the XXXII International Congress of the World Federation of Hemophilia
This interactive carousel features over 500 posters presented at the WFH 2016 World Congress, which can be searched by title, author, poster number, or topic. Via the Options tab on the right, viewers may download, print, or email posters; email poster authors directly; or participate in an online discussion. Presentation slides can also be viewed […]
Abstracts of the XXXII International Congress of the World Federation of Hemophilia
The freely available special Haemophilia Journal supplement dedicated to the WFH 2016 World Congress Orlando (July 2016, Vol 22, Issue Supplement S4 Pages 1–152) features abstracts of many of the posters presented at the Congress, including Late-Breaking Abstracts and those selected for presentation as Free Papers.
Pathogenic or Not? Classification of genetic variants in haemostasis
In the Wednesday morning lab sciences session on the genetic laboratory for bleeding disorders, Anne Goodeve explains the classification of genetic variants in haemostasis.
State of the Art of the XXXII International Congress of the World Federation of Hemophilia
The freely available special Haemophilia Journal supplement dedicated to the WFH 2016 World Congress Orlando (Vol 22, Issue Supplement S5 Pages 1–95) features reviews of the state of the art of each of the topics of the medical plenaries, medical sessions, and laboratory science sessions at the Congress, written by featured speakers.
Diagnosis of von Willebrand Disease (VWD)
In the Wednesday afternoon session on von Willebrand disease (VWD) Jeroen C.J. Eikenboom explains the diagnosis of von Wilebrand Disease (VWD).
Management of Women with VWD
In the Sunday afternoon joint Laboratory Sciences and VWD Professional Development Workshop, Andra H. James explains the unique issues in the management of women with von Willebrand Disease (VWD). This talk was part of the joint Laboratory Sciences and VWD Professional Development Workshop. See below for the other talks in this workshop:
Stem Cell Gene Therapy of Hemophilia A
In the Tuesday morning session on gene therapy, Christopher B. Doering presents advances in stem cell gene therapy of hemophilia A.
Genomics of Platelet Disorders
In the Wednesday morning medical plenary session, Andrew Mumford presents an overview of the genomics of platelet disorders.
Novel Assays for von Willebrand Factor (VWF) Functional Activity
In the Sunday afternoon joint Laboratory Sciences and VWD Professional Development Workshop, Imre Bodó, explores new von Willebrand factor (VWF) activity assays. This talk was part of the joint Laboratory Sciences and VWD Professional Development Workshop. See below for the other talks in this workshop: